RhumbLine Advisers’s Global Blood Therapeutics, Inc. GBT Stock Holding History

RhumbLine Advisers’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-89,339	Closed	-$6.08M	–	3081
2022 Q3	$6.08M	Buy	89,339 +15,894	+22%	+$1.08M	0.01%	1123
2022 Q2	$2.35M	Buy	73,445 +8,466	+13%	+$271K	﹤0.01%	1687
2022 Q1	$2.25M	Buy	64,979 +1,876	+3%	+$65K	﹤0.01%	1755
2021 Q4	$1.85M	Buy	63,103 +236	+0.4%	+$6.91K	﹤0.01%	1928
2021 Q3	$1.6M	Buy	62,867 +1,877	+3%	+$47.8K	﹤0.01%	2019
2021 Q2	$2.14M	Buy	60,990 +757	+1%	+$26.5K	﹤0.01%	1920
2021 Q1	$2.45M	Sell	60,233 -3,324	-5%	-$135K	﹤0.01%	1818
2020 Q4	$2.75M	Sell	63,557 -2,576	-4%	-$112K	﹤0.01%	1684
2020 Q3	$3.65M	Sell	66,133 -3,739	-5%	-$206K	0.01%	1350
2020 Q2	$4.41M	Sell	69,872 -15,215	-18%	-$961K	0.01%	1285
2020 Q1	$4.35M	Buy	85,087 +2,743	+3%	+$140K	0.01%	1110
2019 Q4	$6.55M	Buy	82,344 +3,924	+5%	+$312K	0.01%	1092
2019 Q3	$3.81M	Buy	78,420 +671	+0.9%	+$32.6K	0.01%	1339
2019 Q2	$4.09M	Buy	77,749 +7,220	+10%	+$380K	0.01%	1311
2019 Q1	$3.73M	Buy	70,529 +4,048	+6%	+$214K	0.01%	1349
2018 Q4	$2.73M	Buy	66,481 +21,302	+47%	+$874K	0.01%	1460
2018 Q3	$1.72M	Sell	45,179 -3,439	-7%	-$131K	﹤0.01%	1741
2018 Q2	$2.2M	Buy	48,618 +12,622	+35%	+$571K	﹤0.01%	1628
2018 Q1	$1.74M	Sell	35,996 -1,014	-3%	-$49K	﹤0.01%	1688
2017 Q4	$1.46M	Sell	37,010 -5,731	-13%	-$225K	﹤0.01%	1778
2017 Q3	$1.33M	Buy	42,741 +940	+2%	+$29.2K	﹤0.01%	1843
2017 Q2	$1.14M	Buy	41,801 +22,670	+118%	+$620K	﹤0.01%	1880
2017 Q1	$705K	Buy	19,131 +2,089	+12%	+$77K	﹤0.01%	2096
2016 Q4	$246K	Buy	17,042 +4,156	+32%	+$60K	﹤0.01%	2588
2016 Q3	$297K	Buy	12,886 +1,215	+10%	+$28K	﹤0.01%	2489
2016 Q2	$194K	Buy	+11,671	New	+$194K	﹤0.01%	2756
2016 Q1	–	Sell	-6,255	Closed	-$202K	–	2999
2015 Q4	$202K	Buy	+6,255	New	+$202K	﹤0.01%	2792